The effect of perfusion of the cerebral ventricles with artificial cerebrospinaJ fluid containing carbachol on the blood flow in the caudate nucleus of the cat and the possibility to inhibit this effect by anticholinergic drugs was studied by means of the hydrogen clearance technique. After a control period during which both lateral ventricles were perfused with artificial CSF of Identical composition, the drug under study was added on one side (experimental side) while the other side continued to be perfused with the control artificial CSF (control side). The blood flow on the experimental side and on the control side were compared.
M) and hexamethonium (10~3M). The fall In CBF observed with the high carbachol concentration was prevented by atropine (10~sM).
It may be concluded that low, physiologically more meaningful, carbachol concentrations cause a local vasodilatation due to interaction with both muscarinic and nicotinic receptors. Stroke VOL 15, No 3, 1984 THE PRESENCE OF MUSCARINIC RECEPTORS in the cerebral arteries can be inferred from the fact that the direct application of a low concentration of acetylcholine (Ach) to isolated pial arteries causes a dosedependent dilatation that is competitively blocked by atropine. High concentrations of Ach on the other hand have a constrictor effect which is also antagonized by atropine. 1 " 4 An atropine sensitive dilatation was also observed when carbachol was applied directly to the pial arteries in situ. 5 -6 The presence of muscarinic receptors has drawn attention to the possible influence of cholinergic innervation on the regulation of cerebral blood flow. Evidence for the existence of such a cholinergic innervation in the pial vessels was deduced from histochemical or biochemical measurements of cholinesterase, cholineacetyltransferase and choline uptake. 7 " 13 The results of studies of the possible vasodilating effect of cholinergic innervation on the pial vessels are, however, controversial. 14 -" Stimulation of the superficial petrosal nerve was observed by some investigators to cause an atropine sensitive dilatation of the pial vessels and to increase cerebral blood flow 16 " 18 but this was not always confirmed. 19 It has also been reported that neurogenic vasodilatation is not completely blocked by atropine; this suggests that there may be a component of neurogenic dilatation in the cerebral blood vessels which is not mediated by muscarinic receptors. This is in line with results of experiments with transmural nerve stimulation of cerebral arteries in vitro. This brought Lee et al 20 and Duckies 21 to conclude that the vasodilator transmitter is non-cholinergic, Lee 3 hypothesized that Ach is probably a direct vasoconstrictor whereas its dilatation effect is produced by the release of a relaxing substance from endothelial cells, thus assuming an underlying vasodilating mechanism similar to the one Furchgott and Zawadski 22 described for other blood vessels.
Few studies have examined the presence of muscarinic receptors in the intraparenchymatous cerebral vessels. It was also reported that cholinergic innervation, which is well established for pial arteries, 9 -10 apparently does not extend to the intraparenchymal arteries, 23 although more recent evidence would suggest that they do. 24 Aubineau et al 23 observed in rabbits that infusion with carbachol increased blood flow in the caudate nucleus and that this effect was antagonized by atropine. The decrease of local cerebral blood flow following postganglionic stimulation of the cervical sympathetic chain above the superior cervical ganglion was reduced during the infusion with carbachol; this effect was not affected by atropine.
The aim of the present study was to examine the effect of perivascular application of the cholinergic agonist carbachol on the local cerebral blood flow in the caudate nucleus of the cat. maintained by gallamine (5 mg/kg every hour) and artificial ventilation with nitrous oxyde (30% O 2 , 70% N 2 O). Blood gases were controlled and the animals were kept in steady state normocapnia ( P a^ 30-40 mm Hg) by adjusting the ventilation. Blood pressure was monitored throughout the experiment; in the experiments reported mean blood pressure was at least 100 mm Hg.
Bilateral ventriculocisternal perfusion (VCP) was installed as described previously.
26 -27 Two inlet-cannulas, one on each side, were lowered into the lateral cerebral ventricles by means of a microdrive system. Through each cannula, artificial cerebrospinal fluid (CSF) was administered at the rate of 0.123 ml/min.
An outlet cannula was introduced into the suboccipital cistern. The perfusion pressure on either side was continuously monitored.
The composition of the artificial CSF was as follows (mmol/1): NaCl 138; KC1 3.3; NaHCO 3 The substances under study were added to the artificial CSF. The osmolality and the bicarbonate concentration were carefully checked and when necessary adjusted to 320 mOsm/kg and 25 mmol/1 respectively.
Blood Flow Measurement
Blood flow in both caudate nuclei was measured simultaneously by means of the hydrogen clearance method.
28 -29 A hydrogen sensitive electrode (glass insulated platinized platinum iridium wire 0 0.35 mm) was placed stereotaxically in the head of each caudate nucleus (coordinates A l7 ; L 4 , H } according to the stereotaxic atlas of Snider and Niemer 30 ). The animals were saturated with hydrogen by adding 10% hydrogen gas to the inspired air. The administration of hydrogen was discontinued after a saturation period of at least 10 minutes.
The local CBF was calculated from the hydrogen desaturation curves in a semi-automatized manner as described earlier.
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The blood flow in both caudate nuclei was measured simultaneously and the "blood flow ratio E/C" (flow on the experimental side/flow on the control side, cf. below) was calculated.
Experimental Design
Each experiment started with a "control period" during which both lateral ventricles were perfused with mock CSF of the same composition (pure or with drugs added). Three control flow measurements were made at intervals of 45 min. The first flow measurement was made one hour after the start of the ventriculocisternal perfusion.
After the third control measurement, the composition of the perfusion fluid was changed on one side (experimental side : E) whereas on the other side (control side : C) perfusion was continued with the same solution as during the control period (t = 0). During the "experimental period" three or four flow measurements were made at intervals of 45 min.
Effects of Carbachol
Several series of experiments were performed. After a control period of symmetrical perfusion with "pure" mock CSF, carbachol was added to the perfusion fluid on the experimental side in concentrations of 10-' (n = 7) and 10" 3 M (n = 3). Low (10" 5 M) and high (10~3M) carbachol concentrations were tested in separate groups of animals. During preliminary experiments carbachol concentrations of 10^M as well as 10-*M were tested in a few animals.
In another series of experiments the effects of carbachol were studied following the administration of atropine. After a control period of symmetrical perfusion with mock CSF containing atropine (10~5M), carbachol 10-5 M (n = 8) or 10" 3 M (n = 5) was added to the perfusion fluid on the experimental side. Low (10~3M) and high (10~3M) carbachol concentrations were tested in separate groups of animals.
The effect of carbachol (10" 5 M) was also examined in the presence of hexamethonium. After a control period of symmetrical perfusion with mock CSF containing hexamethonium 10" 3 M (n = 7), carbachol 10~5M was added to the perfusion fluid on the experimental side. The relative concentrations of the antagonists (atropine or hexamethonium) versus the agonist (carbachol) were deduced from in vitro studies. 1 In order to evaluate the results the blood flow ratio (R = E/C) at the end of the control period (t = 0) and at the end of the experimental period (t = 135 min and t = 180 min for the high and low concentrations of carbachol respectively) were compared. The results were analyzed statistically by means of the t-test for paired observations.
Results

Effect of Different Concentrations of Carbachol on Blood Flow in the Caudate Nucleus
The effect of a concentration of 10~5M carbachol was studied in a group of seven animals. The mean values of blood flow in the control period varied between 81 and 74 ml-min"'-100 g~' on the control side and between 74 and 71 ml-min" 1 -100 g~' on the experimental side (table 1). The addition of carbachol (10~5M) caused an increase of the blood flow in the caudate nucleus on the experimental side of about 25%, whereas the blood flow in the caudate nucleus on the control side remained practically unchanged. The blood flow ratio (R = E/C) increased from 0.96 ± 0.14 at t = Oto 1.27 ± 0.13 at t = 180 (p < 0.01), which indicates that there was vasodilatation on the experimental side ( fig. 1A ).
The addition of 10" 4 or lCr^M carbachol similarly produced vasodilatation, but the effect was much less pronounced.
The addition of 10~5M carbachol to the ventricular perfusate did not produce any systemic cardiovascular effects so that the general hemodynamic parameters did not change throughout the experiment.
The effect of a high carbachol concentration was tested in another group of animals. After adding 10~3M carbachol, the blood flow in the caudate nucleus on the
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Time ( experimental side decreased significantly (30%). The mean values of the blood flow during the control period (t = -90 to t = 0) varied between 107 and 99 ml-min" 1 -100 g"' on the control side and between 129 and 114 ml-min'• 100 g"' on the experimental side. After 135 min blood flow dropped to 72 ± 2ml-min-'-100 g" 1 on the experimental side whereas on the control side only a slight decrease was observed. The resulting blood flow ratio (R = E/C) decreased from 1.15 ± 0.08 at t = 0 to 0.86 ± 0.06 at t = 135 ( fig. 2A) . This large dose of carbachol was generally badly tolerated by the animals and caused a gradual but important fall in blood pressure. The results in table 1 bear upon three animals of which tHe mean arterial blood pressure remained higher than 100 mm Hg throughout the experiment.
Effects of Atropine and Hexamethonium on the Response to Carbachol
In a second series of experiments the effect of carbachol was studied in the presence of acetylcholine receptor antagonists. After bilateral addition of antagonists to the perfusate, 10~5M carbachol was added to the side initially showing the lowest blood flow. This was done in order to detect any possible vasodilatation more easily.
When both lateral ventricles were perfused with artificial CSF containing atropine (10" 5 M) blood flow in the caudate nuclei varied in 8 animals between 125 and 116 ml-min" 1 -100 g" 1 on the control side and between 111 and 103 ml-min" 1 -100 g" 1 on the experimental side. After the unilateral addition of carbachol (10~5M) the blood flow ratios between the experimental and control sides of the individual animals showed a small increase indicating some resting vasodilatation on the experimental side in contact with carbachol ( fig. IB) . That ratio was 0.88 ± 0.08 at t = 0 and 0.97 ± 0.09 at t = 180. This rise in blood flow ratio is statistically not significant (p > 0.2).
The effect of carbachol (10~5M) was also antagonized by hexamethonium. When both iateral ventricles of 7 cats were perfused with artificial CSF containing hexamethonium (10" 
Discussion
The experiments show that the addition of carbaclhol to the ventricular fluid affects blood flow in the adjacent caudate nucleus. Since CBF measurements were made before and after adding carbachol, each animal served as its own control; moreover the asymmetrical perfusion and the simultaneous CBF measurement on both sides allowed to differentiate between local effects of carbachol and more general effects.
The experiments show that ventriculo-cisternal perfusion with low concentrations of carbachol causes blood flow in the caudate nucleus to increase as a result of local vasodilatation.
The optimal vasodilatory effect was obtained with carbachol 1O" tylcholine (or carbachol) concentrations than the ones we used. Several factors can explain the need for higher concentrations in our experiments. Firstly, the concentration of carbachol in the ventricular CSF was undoubtedly lower than in the infused artificial CSF because of the addition of freshly secreted endogenous CSF. Secondly, carbachol had to diffuse into the periventricular brain tissue before its effect on the blood flow in the caudate nucleus could be detected by the method used in the experiments. Because of this diffusion gradient the concentration of carbachol in the extracellular fluid of the caudate nucleus where the blood flow was measured, can be accepted to be much lower than that in the ventricular CSF. For histamine it was found that after 1 hour of epiarachnoid irrigation, the mean concentration of exogenous histamine in the first mm of the brain subjacent to the irrigating solution was only approximately 15% of the concentration of histamine in the irrigation fluid.
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Experiments in which very large doses of carbachol (10~3M) were used, showed a manifest decrease of the blood flow in the caudate nucleus due to local vasoconstriction. Our in vivo experiments confirm the dual effect observed on in vitro preparations: vasodilatation of isolated segments of cerebral arteries with low concentrations (up to 10^M) of acetylcholine and vasoconstriction with high concentrations (> lO^M). 1 The high concentrations, however, caused general circulatory changes (blood pressure fall) in most animals; in the three experiments described the mean arterial blood pressure remained higher than 100 mm Hg throughout the experiment.
The effect of the classical anticholinergic drugs allows to speculate about the receptor type involved. Atropine (10~5M) clearly impedes the dilatation caused by carbachol (I0~3M) as well as the vasoconstriction caused by carbachol (10~3M). When administered intraventricularly after treatment with atropine, carbachol (10~5M) only produced a small and insignificant vasodilatation.
Our experiments thus show that muscarinic recep- 
Addition of carbachol IO~3M causes vasoconstriclion (A) which is inhibited by atropine (B).
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tors are involved in the dilator as well as in the constrictor response to carbachol. In this respect our results confirm the experimental data concerning the effect of cholinomimetics on isolated cerebral blood vessels and on pial vessels reported in the literature 1 -31 and they extend those observations to the deeper parenchymal blood vessels. Our findings are also in line with the results of in vivo studies using intravascular administration of cholinomimetic drugs in different animal species. 16 -25 -33 - 35 Besides the presence of muscarinic receptors the results of our experiments also show that nicotinic receptors play a part in the vasodilator response to low concentration of carbachol as hexamethonium (10" 3 M) proved to prevent the vasodilatation by carbachol.
The possible involvement of nicotinic receptors in the regulation of the cerebrovascular tone has already been demonstrated in vitro by Edvinsson et al. 1 Acetylcholine was found to affect the cerebrovascular tone through presynaptic inhibition of vascular sympathetic discharge and this effect was mediated by nicotinic receptors. This is in contrast with other vascular beds, where a similar effect is mediated by muscarinic receptors. 35 Moreover it has been demonstrated that the fall in CBF as well as the pial artery constriction caused by sympathetic stimulation can be reduced by carbachol (or acetylcholine) and that this effect is not affected by atropine; it may therefore be concluded that it is caused by a nonmuscarinic mechanism. 36 3738 Provided there is a resting sympathetic tone in the vascular bed under study, the inhibition of the release of noradrenaline from the vascular sympathetic nerve endings may contribute to the increase in CBF caused by carbachol.
In addition to a direct interaction with vascular receptor sites, cholinomimetic drugs can affect the cerebral blood flow in an indirect way also. This is possible on account of the coupling which normally exists between function and blood flow. In the striatum (caudate-putamen) the greater part of the cholinergic innervation is supposed to be intrinsic and predominantly facilitating with respect to striatal cells. Cholinergic mechanisms in the central nervous system involve both muscarinic and nicotinic receptors. In the brain as a whole more muscarinic than nicotinic receptors seem to be present and they are especially numerous in the caudate nucleus. 39 It may therefore be assumed that superfusion of the caudate nuclei with artificial CSF containing carbachol excites striatal cells mainly through the activation of muscarinic receptors. Coupling between function and blood flow then would induce vasodilatation. The fact, however, that the administration of cholinomimetic drugs increases CBF even after inhibition of the neuronal activity by means of GABA or MgSO 4 6 indicates that such an indirect mechanism is not necessarily involved.
In summary, our experiments show that superfusion of the caudate nucleus with solutions containing lower concentrations of carbachol causes vasodilatation whereas high unphysiological concentrations of carbachol cause vasoconstriction. Both muscarinic and nicotinic receptors are active on the vascular bed under study. 
